撤回:李等人. 基于机器学习的割抗性前列腺癌的生存预测:使用综合临床数据集的多模型分析. 一个叫J.J.的小孩. 个人 个人 个人 在2025年中,15年,432年
Jeong Hyun Lee1, Jaeyun Jeong2, Young Jin Ahn1
1Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul 06273, Republic of Korea.
Journal of personalized medicine
|February 2, 2026
概括
这项关于机器学习用于割抵抗性前列腺癌存活率预测的研究已被撤回. 这篇文章不再被认为是有效的科学文献.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 计算生物学 计算生物学
背景情况:
- 预测前列腺癌的生存率对于治疗计划至关重要.
- 抗割前列腺癌 (CRPC) 在预后方面提出了独特的挑战.
- 机器学习 (ML) 提供了改善生存预测模型的潜力.
研究的目的:
- 分析多个机器学习模型的性能,以预测CRPC中的生存率.
- 评估综合临床数据集对基于ML的生存预测的有用性.
- 为CRPC预后确定可靠的ML方法.
主要方法:
- 使用了针对CRPC患者的综合临床数据集.
- 开发和分析了多个机器学习算法.
- 进行了多模型分析,以比较预测准确度.
主要成果:
- 这项研究旨在介绍关于ML模型对CRPC存活率的性能.
- 有关模型准确性和特征重要性的具体结果是预期的.
- 对不同的ML方法进行了比较分析.
结论:
- 该文章已被撤回,其调查结果无效.
- 科学界应该无视本文中提出的结论.
- 撤回意味着研究的完整性或有效性存在问题.
更多相关视频
相关概念视频
Cancer Survival Analysis
765
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
765
Introduction To Survival Analysis
789
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
789
Comparing the Survival Analysis of Two or More Groups
602
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
602
Truncation in Survival Analysis
621
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
621
Assumptions of Survival Analysis
425
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
425
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K


